Seeing Is Believing
Currently, out of the existing stock ratings of Jami Rubin - 43 which are a Buy (46.24%), 32 which are a Hold (34.41%), 18 which are a Sell (19.35%)
Analyst Jami Rubin was covering the Healthcare sector with 186 price targets and ratings displayed on 13 stocks. Previously, Jami Rubin worked at GOLDMAN SACHS.
Jami Rubin's average stock forecast success ratio is 79.49% with an average time for price targets to be met of 449.31 days.
Most recent stock forecast was given on TEVA, Teva Pharmaceutical Industries at 01-Oct-2018.
Analyst best performing recommendations are on PRGO (PERRIGO COMPANY PLC).
The best stock recommendation documented was for PRGO (PERRIGO COMPANY PLC) at 1/30/2017. The price target of $75 was fulfilled within 16 days with a profit of $8.52 (12.82%) receiving and performance score of 8.01.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average time for PT to be met
Performance score
Buy
170
$16.39 (10.67%)
163
1 months 24 days ago
33/34 (97.06%)
$24.97 (28.96%)
433
Buy
182
$28.39 (18.48%)
181
2 months 10 days ago
6/15 (40%)
$28.98 (32.96%)
467
Buy
155
5 months 16 days ago
1/1 (100%)
$21 (15.67%)
90
Buy
172
$18.39 (11.97%)
166
6 months 20 days ago
23/24 (95.83%)
$22.65 (31.91%)
519
Hold
127
6 months 30 days ago
1/1 (100%)
$21.13 (19.96%)
240
What Year was the first public recommendation made by Jami Rubin?